» Articles » PMID: 17850917

A SAS Macro for Estimation of Direct Adjusted Survival Curves Based on a Stratified Cox Regression Model

Overview
Date 2007 Sep 14
PMID 17850917
Citations 146
Authors
Affiliations
Soon will be listed here.
Abstract

Often in biomedical research the aim of a study is to compare the outcomes of several treatment arms while adjusting for multiple clinical prognostic factors. In this paper we focus on computation of the direct adjusted survival curves for different treatment groups based on an unstratified or a stratified Cox model. The estimators are constructed by taking the average of the individual predicted survival curves. The method of direct adjustment controls for possible confounders due to an imbalance of patient characteristics between treatment groups. This adjustment is especially useful for non-randomized studies. We have written a SAS macro to estimate and compare the direct adjusted survival curves. We illustrate the SAS macro through the examples analyzing stem cell transplant data and Ewing's sarcoma data.

Citing Articles

Adjusted curves for clustered survival and competing risks data.

Khanal M, Kim S, Ahn K Commun Stat Simul Comput. 2025; 54(1):120-143.

PMID: 39790711 PMC: 11708817. DOI: 10.1080/03610918.2023.2245583.


Mortality, Hospitalization, and Cardiac Interventions in Patients With Atrial Fibrillation Aged <65 Years.

Bhonsale A, Zhu J, Thoma F, Koscumb S, Kancharla K, Voigt A Circ Arrhythm Electrophysiol. 2024; 17(5):e012143.

PMID: 38646831 PMC: 11111318. DOI: 10.1161/CIRCEP.123.012143.


Representativeness of the PIONEER-HF and PARAGLIDE-HF in patients hospitalized with acute heart failure.

Chen D, Chen C, Lee C, Tseng C, Chen S, Chang S ESC Heart Fail. 2024; 11(4):2259-2271.

PMID: 38638078 PMC: 11287328. DOI: 10.1002/ehf2.14761.


Impact of thiotepa dose-intensity in primary diffuse large B-cell lymphoma of the central nervous system undergoing autologous hematopoietic cell transplant with thiotepa/carmustine conditioning.

Arshad S, Fang X, Ahn K, Kaur M, Scordo M, Sauter C Bone Marrow Transplant. 2023; 58(11):1203-1208.

PMID: 37563283 PMC: 11078515. DOI: 10.1038/s41409-023-02071-8.


Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.

Bolanos-Meade J, Hamadani M, Wu J, Al Malki M, Martens M, Runaas L N Engl J Med. 2023; 388(25):2338-2348.

PMID: 37342922 PMC: 10575613. DOI: 10.1056/NEJMoa2215943.